A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing antibodies, but not memory T cells, than the homologous BNT162b2 regimen

BACKGROUND: Comparative analyses of SARS-CoV-2-specific immune responses elicited by diverse prime-boost regimens are required to establish efficient regimens for the control of COVID-19. METHOD: In this prospective observational cohort study, spike-specific immunoglobulin G (IgG) and neutralizing a...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Yae Jee, Kim, Woo-Joong, Ko, Jae-Hoon, Lee, Youn-Jung, Ahn, Jin Young, Kim, Jung Ho, Jang, Ho Cheol, Jeong, Hye Won, Kim, Yong Chan, Park, Yoon Soo, Kim, Sung-Han, Peck, Kyong Ran, Shin, Eui-Cheol, Choi, Jun Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901539/
https://www.ncbi.nlm.nih.gov/pubmed/36754764
http://dx.doi.org/10.1016/j.vaccine.2023.01.063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901539/
https://www.ncbi.nlm.nih.gov/pubmed/36754764
http://dx.doi.org/10.1016/j.vaccine.2023.01.063

Ejemplares similares